Skip to main content
. 2017 Jan 27;8(12):18914–18923. doi: 10.18632/oncotarget.14835

Figure 3. IL-17B up-regulated the stemness of MSC.

Figure 3

(A and C) Western blot analyses of Sox2, Oct4 and Nanog levels in hucMSCs (A) and GC-MSCs (C) treated with/without 100 ng/ml and 200 ng/ml rIL-17B for 48 hours. (B and D). Quantitative analyses for relative mRNA levels of Oct4, Sall4 and Nanog in hucMSCs (B) and GC-MSCs (D) treated with/without 100 ng/ml and 200 ng/ml rIL-17B for 48 hours. (E) HucMSCs and GC-MSCs treated with corresponding concentrations of rIL-17B for 48 h, and then induced with adipogenic differentiation medium. Representative images show accumulation of lipid droplets after undergoing adipogenic differentiation. All samples were measured in triplicate, *p < 0.05, **p < 0.01, ***p < 0.001.